pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    TH-3215
    Solid Tumor$CNTN Canton Strategic Holdings, Inc.
  • THALLOUS CHLORIDE TL 201
    THALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE, TL 201)
    no indication CURIUM
  • THIAMINE HYDROCHLORIDE
    THIAMINE HYDROCHLORIDE
    no indication SAGENT PHARMS INC
  • Phase 3
    THRV-1268
← prev
page 140 of 231
next →
131
Pain89
Neurology1
Arrhythmias
$THRY Thryv Holdings, Inc.
  • Phase 2
    TILT-123
    Ovarian Cancer TILT Biotherapeutics Ltd
  • TIMOLOL HEMIHYDRATE
    TIMOLOL HEMIHYDRATE
    no indication SOMERSET THERAPS LLC
  • TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION
    TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION
    no indication GLAND
  • TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%
    TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%
    no indication ALEMBIC
  • TIROFIBAN
    TIROFIBAN
    no indication EUGIA PHARMA
  • TISSUEBLUE
    TISSUEBLUE (BRILLIANT BLUE G)
    no indication DUTCH OPHTHALMIC
  • Phase 1
    TIX-100
    Type 1 Diabetes (Juvenile Diabetes) Tiximed Inc
  • Preclinical
    TJ-106
    Breast Cancer Phrontline Biopharma Co Ltd
  • Preclinical
    TLC-1235
    Insulin Resistance OrsoBio Inc
  • pre_registration
    TLD-002
    Unspecified Metabolic Disorders Tilde Sciences LLC
  • Phase 2
    TLD-1433
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… Theralase Technologies Inc
  • Phase 2
    TLL-018
    Plaque Psoriasis (Psoriasis Vulgaris) Hangzhou Highlightll Pharmaceutical Co Ltd
  • Phase 3
    TLL-041
    Parkinson's Disease$BHVN Biohaven Ltd.
  • Phase 2
    TLP-02
    Metablok
    Acute Respiratory Distress Syndrome Arch Biopartners Inc
  • Phase 1
    TLX-090
    Cyclosam
    Bone Metastasis$TLX Telix Pharmaceuticals Ltd
  • Preclinical
    TLX-102
    Malignant Glioma$TLX Telix Pharmaceuticals Ltd
  • Phase 2
    TLX-250
    Metastatic Renal Cell Carcinoma$TLX Telix Pharmaceuticals Ltd
  • Phase 1
    TLY-012
    Chronic Pancreatitis D&D Pharmatech Co Ltd
  • Phase 2
    TMB-365
    Human Immunodeficiency Virus (HIV) Infections (AIDS) TaiMed Biologics Inc
  • Phase 2
    TMB-365 + TMB-380
    Human Immunodeficiency Virus (HIV) Infections (AIDS) TaiMed Biologics Inc
  • Phase 1
    TML-6
    Alzheimer's Disease Merry Life Biomedical Co Ltd
  • Phase 2
    TN-201
    Hypertrophic Cardiomyopathy$TNYA Tenaya Therapeutics, Inc.
  • Phase 1
    TN-301
    Diastolic Heart Failure (HFpEF)$TNYA Tenaya Therapeutics, Inc.
  • Phase 2
    TN-401
    Cardiomyopathy$TNYA Tenaya Therapeutics, Inc.
  • Phase 2
    TNG-260
    Cervical Cancer$TNGX Tango Therapeutics, Inc.
  • Phase 2
    TNG-456
    Bladder Cancer$TNGX Tango Therapeutics, Inc.